Spots Global Cancer Trial Database for Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
Official Title: Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
Study ID: NCT00898170
Interventions
Study Description
Brief Summary: The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.
Detailed Description: Background: Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis. Patients \& Methods: In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.
Eligibility
Minimum Age: 22 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Cardiology Ward Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
Contact Details
Name: javad kojuri, M.D.
Affiliation: Shiraz University of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
